2X Match My Gift
This National Cancer Survivors Month, your gift is matched to expand treatment options and bring more patients into survivorship through Project Cure CRC.

Every day, patients and families face the devastating impact of colorectal cancer — the second leading cause of cancer-related deaths in the U.S. But hope is on the horizon.
Project Cure CRC, a groundbreaking initiative from the Colorectal Cancer Alliance, is transforming how we treat this disease through science, data, and a national network.
This video shares the voices of volunteer survivors and caregivers — those who represent the personal meaning and life-saving power of Project Cure CRC.
Learn how you can fuel this revolution in cancer care.
Together, we can triple survivorship!

A first-of-its-kind trial platform in the colorectal cancer space, Project Cure CRC’s KLEOS is being driven by the Colorectal Cancer Alliance, the leading nonprofit dedicated to ending the disease, in collaboration with GCAR, a pioneer in the design and implementation of innovative clinical trials.

The Colorectal Cancer Alliance will present three poster sessions and deliver an oral presentation at the American Association for Cancer Research Annual Meeting 2026.

hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.